INNOVACAP

Innova Captab Share Price

 

 

Invest in Innova Captab with 2.07X leverage

Invest with MTF

Performance

  • Low
  • ₹699
  • High
  • ₹747
  • 52 Week Low
  • ₹660
  • 52 Week High
  • ₹1,260
  • Open Price₹720
  • Previous Close₹726
  • Volume37,223

Investment Returns

  • Over 1 Month -3.64%
  • Over 3 Month -14.33%
  • Over 6 Month -16.52%
  • Over 1 Year -30.98%

Smart Investing Starts Here Start SIP with Innova Captab for Steady Growth!

Invest Now

Innova Captab Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 34
  • PEG Ratio
  • 6.6
  • Market Cap Cr
  • 4,232
  • P/B Ratio
  • Average True Range
  • 33.44
  • EPS
  • 21.75
  • Dividend Yield
  • 0
  • MACD Signal
  • -22.16
  • RSI
  • 50.05
  • MFI
  • 46.04

Innova Captab Financials

Innova Captab Technicals

EMA & SMA

Current Price
₹739.60
+ 13.45 (1.85%)
pointer
  • Bearish Moving Average 8
  • Bullish Moving Average 8
  • 20 Day
  • ₹729.38
  • 50 Day
  • ₹769.31
  • 100 Day
  • ₹808.44
  • 200 Day
  • ₹826.17

Resistance and Support

728.52 Pivot Speed
  • R3 805.98
  • R2 776.47
  • R1 758.03
  • S1 710.08
  • S2 680.57
  • S3 662.13

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Innova Captab Ltd. is a leading pharmaceutical company in India, specializing in the manufacturing of formulations, including tablets, capsules, and syrups. It caters to domestic and international markets with a focus on quality and innovation.

Innova Captab Ltd has an operating revenue of Rs. 1,363.13 Cr. on a trailing 12-month basis. An annual revenue growth of 15% is outstanding, Pre-tax margin of 14% is healthy, ROE of 13% is good. The company has a reasonable debt to equity of 25%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 23 which is a POOR score indicating inconsistency in earnings, a RS Rating of 31 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 76 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Innova Captab Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-07 Quarterly Results
2025-08-07 Quarterly Results
2025-05-19 Audited Results
2025-02-05 Quarterly Results & Others To consider other business matters.
2024-11-07 Quarterly Results

Innova Captab F&O

Innova Captab Shareholding Pattern

50.9%
10.69%
1.96%
0.08%
27.35%
9.02%

About Innova Captab

  • NSE Symbol
  • INNOVACAP
  • BSE Symbol
  • 544067
  • Managing Director
  • Mr. Vinay Kumar Lohariwala
  • ISIN
  • INE0DUT01020

Similar Stocks to Innova Captab

Innova Captab FAQs

Innova Captab share price is ₹739 As on 10 December, 2025 | 20:47

The Market Cap of Innova Captab is ₹4232.4 Cr As on 10 December, 2025 | 20:47

The P/E ratio of Innova Captab is 34 As on 10 December, 2025 | 20:47

The PB ratio of Innova Captab is 4.4 As on 10 December, 2025 | 20:47

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23